Document 0121 DOCN M9480121 TI DNA found in human immunodeficiency virus type 1 particles may not be required for infectivity. DT 9410 AU Arts EJ; Mak J; Kleiman L; Wainberg MA; Lady Davis Institute, Jewish General Hospital, Montreal,; Quebec, Canada. SO J Gen Virol. 1994 Jul;75 ( Pt 7):1605-13. Unique Identifier : AIDSLINE MED/94292911 AB We have studied the presence and significance of retroviral genome-derived DNA in the core of human immunodeficiency virus (HIV) particles produced from transfections of HXB2 expression vectors in COS-7 cells and from HIV type 1 IIIB chronically infected H9 cells. Viruses purified by sucrose cushion centrifugation and treated with DNase I contained 1000-fold more viral RNA than DNA. However, protease-defective viruses that contained only p160gag-pol had less than 100 times the amount of DNA in their cores than wild-type viruses suggesting that the p66/p51 form of reverse transcriptase was responsible for DNA transcription. Viruses produced by transfections in the presence of 3'-azido-3'-deoxythymidine (AZT) contained the viral RNA genome but only DNA of premature length because of the chain terminating effects of AZT. However such viruses were as infections for CD4+ cells as wild-type virus. We conclude that retrovirus-derived DNA in HIV-1 particles is not required for infection and does not play a significant role in this process. DE Animal Cell Line DNA, Viral/*ANALYSIS Gene Amplification Gene Products, gag/PHYSIOLOGY *Genome, Viral Human HIV Core Protein p24/ANALYSIS HIV-1/CHEMISTRY/*GENETICS/PHYSIOLOGY Polymerase Chain Reaction Protein Precursors/PHYSIOLOGY Reverse Transcriptase/PHYSIOLOGY RNA, Viral/ANALYSIS/GENETICS Support, Non-U.S. Gov't T-Lymphocytes/CYTOLOGY Transfection Virus Replication/DRUG EFFECTS Zidovudine/PHARMACOLOGY JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).